Developing cellular therapeutics with:

• allogeneic human umbilical cord-derived mesenchymal stem cells (huMSC)
• huMSC-derived mesenchymal trophic factors (MTF)
• autologous adipose-derived stromal vascular fraction (SVF)
• autologous bone marrow-derived mononuclear cells (BMMC)

We are currently recruiting participants for our clinical trials. For more information please click on the links to the right.

If you are interested in participating please contact us today for more information.